Most Read News


Dong-A Socio, Alteogen & DMBio signs contract service agreement of macular degeneration treatment

Alteogen(CEO Soon-Jae Park), a company which are developing a biosimilar of macular degeneration treatment ‘Eylea,’ announced on the 28th that it signed a Eylea biosimilar manufacturing agreement with DMBio(Byung-Jo M...

Distribution industry getting tense over launches of generics, like Viread and Dexid

Pouring generic medicines produced by patent expiration of large products, such as Tamiflu, have troubled pharmaceutical distribution companies in the 2nd half of the year. For your information, a number of Tamifly g...

Aprogen’s ‘Remicade’ biosimilar break into KRW 1 trillion Japanese market

A ‘Remicade’ biosimilar developed by Aprogen has made a stepping stone to enter the KRW 1 trillion Japanese market. Aprogen(CEO Jae-Seop Kim), a biosimilar company, announced the company acquired approval of its Remi...

More emergency household medicine selling stores than pharmacies

It was surveyed that there are more stores selling emergency household medicines than pharmacies in Korea. According to the Ministry of Health and Welfare, the number of emergency household medicine sellers was total...

Definition of ‘Financial Benefits’ raised at Novartis rebate trial

While the Novartis’s rebate trial continues, a definition of the ‘provision of financial benefits,’ which the prosecution claimed as a base of indictment, became a topic of conversation at the trial. The defense argu...

Sudden decrease of bioequivalently approved medicines by 54% year-on-year

There were 481 medicines newly approved by bioequivalence test this year, which was decreased by more than half compared to the same period of the last year. According to the Ministry of Food and Drug Safety(MFDS), t...

Celltrion selects ‘Oracle’ technology to smoothly manage drug side effects

Oracle announced on the 26th(U.S. local time) that Celltrion chose ‘Oracle Health Sciences Argus’ and ‘Oracle Health Sciences Empirica Signal’ to launch life-saving chronic disease treatments more and cheaper by contr...

Serial Number Committee to carry out preparation of aggregation guideline and demo project

A demo project will be conducted to inspect standardization of medicine aggregation. The Serial Number System Revision Committee on the 26th had discussions about ways to standardize aggregation and combined use or u...

KPA carries out demo project for ‘digitalization of paper prescriptions’

The Korea Pharmaceutical Association(President Chan-Hwi Cho, KPA) signed a memorandum of understanding on the 26th to improve efficiency of delivering prescriptions between hospitals and pharmacies, enhance convenienc...

7 of 10 license-using pharmacists were female in Seoul

6 of 10 license-using pharmacists(pharmacists who actually use pharmacist license for work) were reportedly a female pharmacist. Moreover, farming and fishing areas had a higher ratio of male pharmacists, and urban a...

Ilyang Pharmaceutical’s Supect shows high generic response than Glivec

A phase III clinical trial result of ‘Supect(radotinib),’ the Asia’s first leukemia treatment developed by Ilyang Pharmaceutical, was published an online-version of an international journal ‘Clinical Cancer Research,’...

“We only take returns of medicine directly supplied from us”

While pharmaceutical distribution companies are seeking for solutions for the 1.5 year suspension as an administrative measure from violating the serial number system, some pharmaceutical companies were criticized for...

Lilly’s Trulicity applied for national health insurance benefit in combination with insulin

Lilly Korea(CEO Paul Henry Huibers) announced the Ministry of Health and Welfare’s national health insurance benefit standards were extensively revised under a revision bill for ‘Trulicity(generic name: dulaglutide)’ ...

Yuhan Corporation & Samsung Bioepis sign exclusive biosimilar sales agreement

Yuhan Corporation(CEO Jung-Hee Lee) signed an exclusive sales agreement of the Remicade(generic name: infliximab) biosimilar(SB2) and the Enbrel(generic name: etanercept) biosimilar(SB4) in Korea with Samsung Bioepis(...

Trend to switch delivery services for online drug shopping malls from same-day to overnight

Pharmaceutical distribution companies are seeking for ways to make their delivery system efficient by various methods, such as delaying deliveries or minimizing the number of deliveries in the online medicine market. ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.